Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
OptiNose
0OPCurrent price
0.47 EUR
0 EUR (0.00%)
Last closed
0.6 USD
Company
www.optinose.com
ISIN
US68404V1008
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Frankfurt Exchange
Capitalization
115 826 880 USD
Yield for 12 month
-63.31 %
1Y
3Y
5Y
10Y
15Y
0OP
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase IIIb clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. It has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail. The company was founded in 2000 and is headquartered in Yardley, Pennsylvania. Address: 1020 Stony Hill Road, Yardley, PA, United States, 19067
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
3.5 USDP/E ratio
–Dividend Yield
–Current Year
+70 987 000 USD
Last Year
+76 276 000 USD
Current Quarter
+20 490 000 USD
Last Quarter
+14 880 000 USD
Current Year
+61 952 000 USD
Last Year
+67 013 000 USD
Current Quarter
+18 426 000 USD
Last Quarter
+13 566 000 USD
Key Figures 0OP
1 year
3 years
5 years
10 years
EBITDA
-18 453 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-9.89 %
PEG Ratio
–
Return On Equity TTM
-1050.5 %
Wall Street Target Price
3.5 USD
Revenue TTM
75 058 000 USD
Book Value
-0.29 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
5.3 %
Dividend Yield
–
Gross Profit TTM
67 013 000 USD
Earnings per share
-0.34 USD
Diluted Eps TTM
-0.34 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-54.5 %
Dividend Analytics 0OP
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 0OP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 0OP
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
2.0305
Price Sales TTM
1.5432
Enterprise Value EBITDA
-4.3258
Price Book MRQ
24.2559
Financials 0OP
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 0OP
For 52 weeks
0.65 USD
2.1 USD
50 Day MA
0.78 USD
Shares Short Prior Month
8 429 950
200 Day MA
1.11 USD
Short Ratio
18.83
Shares Short
8 687 573
Short Percent
7.32 %
BeatStart